Recruiting

Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

This is a prospective observational cohort study conducted in Qujiang District, Zhejiang Province, China, aiming to evaluate the effectiveness of a comprehensive management program for elderly patients with chronic cardiovascular diseases (CVDs). The program integrates pharmacological treatment, lifestyle modification, health education, and long-term follow-up, with enhanced monitoring using 7-day ECG recording. The study focuses on major chronic CVDs including hypertension, coronary artery disease, atrial…

ClinicalTrials.gov IDNCT07149688
PhaseNot Applicable
Enrollment30000
SponsorBeijing Anzhen Hospital
Age60 Years
SexALL
I'm interested View official listing

Conditions studied

Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD), Heart Failure

About this study

This is a prospective observational cohort study conducted in Qujiang District, Zhejiang Province, China, aiming to evaluate the effectiveness of a comprehensive management program for elderly patients with chronic cardiovascular diseases (CVDs). The program integrates pharmacological treatment, lifestyle modification, health education, and long-term follow-up, with enhanced monitoring using 7-day ECG recording. The study focuses on major chronic CVDs including hypertension, coronary artery disease, atrial fibrillation, and heart failure. Approximately 30,000 participants aged ≥60 years will be enrolled and followed for up to 10 years.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria Age ≥60 years Resident of Qujiang District Diagnosed with chronic CVD (hypertension, coronary artery disease, heart failure, atrial fibrillation, or others) Able and willing to provide informed consent Exclusion Criteria Severe cognitive impairment or inability to provide consent Life expectancy \<1 year due to non-cardiovascular disease Participation refusal

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.